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Abstract 
Introduction: The angiotensin-converting enzyme gene insertion/deletion polymorphism 
(ACE I/D genotype) has been one of the first and most investigated possible gene marker for 
physical performance. However, studies investigating the association between the ACE I/D 
genotype and peak oxygen uptake (VO2peak) were not conclusive (Papadimitriou et al., 2018; 
Rankinen et al., 2000; Sonna et al., 2001). On the contrary, studies which have focused on 
skeletal muscle had more success (Valdivieso et al., 2017; Vaughan et al., 2016; Vaughan, 
Huber-Abel, Graber, Hoppeler, & Flück, 2013; Zhang et al., 2003). Muscle monitors based on 
near-infrared spectroscopy (NIRS) offer the possibility of non-invasive measurement of skele-
tal muscle oxygenation during exercise. Therefore, the aim of this study was to find out 
whether there are individual and combined effects of the ACE I/D genotype and endurance 
training status on markers of muscle oxygen saturation (SmO2) during ramp test. 
Methods: 21 non-specific trained subjects completed an incremental cycle ergometer test 
(ramp test) and were genotyped for the ACE I/D genotype. During ramp test VO2peak was 
measured with a breath-by-breath system. SmO2 of the m. vastus lateralis was measured us-
ing a NIRS device. The individual and combined effects of the ACE I/D genotype and endur-
ance training status on SmO2 markers during ramp test were analysed using two factor analy-
sis of variance (ANOVA). 
Results: ACE I/D genotype did not have a significant effect on any of the SmO2 markers dur-
ing ramp test. Endurance training status had a significant effect on the markers SmO2 min (p = 
0.017) and ∆deoxygenation (p = 0.033) and a highly significant effect on the marker ∆1/2 reoxygenation 
(p = 0.007). In addition, there was a significant interaction effect between the ACE I/D geno-
type and training status on the marker slopedeoxygenation (p = 0.028). 
Discussion and Conclusion: Possible confounders, such as gender and training status, may 
have influenced a potential individual effect of the ACE I/D genotype. The observed greater 
muscle deoxygenation and reoxygenation in trained subjects could indicate an increased oxi-
dative capacity of the m. vastus lateralis. The highly significant steeper slopedeoxygenation for 
trained subjects only found within the I/I genotype could indicate a higher percentage of slow-
twitch type I muscle fibres and thus a higher mitochondrial density. Based on these results it 
could be speculated that carriers of the I/I genotype could result in greater adaptability in a 
longitudinal training study. This pilot study may serve to obtain insightful data into the possi-
bility of developing specific training programs ad hoc for different patient characteristics. 
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1 Introduction 
Physical performance can be seen as a result from the interaction of nature with nurture. In the 
context of physical performance, the term nature can be further described as genetics, while 
the term nurture describes environmental factors such as physical training and nutrition. The 
human genetic material, also known as genome, consists of deoxyribonucleic acid (DNA) and 
is located in the nucleus of the cell as well as in the mitochondria (Roth, 2007). Minor DNA 
sequence variations contribute to the phenotypic differences, such as anatomy, physiology 
and disease predisposition (Roth & Thomis, 2011). An important goal in the field of exercise 
genomics is to identify potential gene candidates that may have an influence on physical per-
formance and exercise adaptation. Up to 2009, there are 214 autosomal, seven gonosomal and 
18 mitochondrial candidate genes that have been shown to influence physical performance 
(Bray et al., 2009). Among them, sequence variations within the angiotensin-converting en-
zyme (ACE) gene have been one of the first and most investigated gene markers for physical 
performance. The ACE gene contains a DNA sequence variation in form of an inser-
tion/deletion (I/D) polymorphism. An I/D polymorphism is characterized by the presence or 
absence of an entire fragment of a DNA sequence (Roth & Thomis, 2011). Within the ACE 
gene, there is a gene variant in which a 287 base pair long Alu repeat DNA fragment is pre-
sent (I allele) and there is a gene variant in which this DNA fragment is absent (D allele). Ac-
cordingly, there are three possible ACE I/D genotypes: I/I genotype, I/D genotype and D/D 
genotype. 
 
1.1 The ACE I/D genotype distribution 
There is evidence that the distribution of the ACE I/D genotype is associated with ethnic 
origin. In Europe, 80 healthy Caucasians (38 males and 42 females) were found to have an 
allele frequency of 0.4 for the I allele and 0.6 for the D allele (Rigat et al., 1990). In other 
words, 40 out of 100 European Caucasians carried the 287 base pair long Alu repeat DNA 
fragment while 60 out of 100 Europeans did not carry this insertion. According to Barley et 
al. (1994), the frequency ratio for Caucasian Europeans is 1:2:1 for the I/I, I/D and D/D geno-
type, respectively. Interestingly, the authors found that black Nigerians showed a tendency 
towards a higher frequency of the D allele, while Samoan Polynesians and Yanomami Indians 
showed a much higher frequency of the I allele. In addition, Foy et al. (1996) found a lower 
frequency of the D allele in 305 Pima Indians from Arizona compared to 80 Caucasian Amer-
icans. Furthermore, Barley et al. (1996) determined the ACE I/D genotype in a total of 320 
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subjects including 210 Caucasian Europeans and 110 black Afro-Caribbean. The distribution 
of the ACE I/D genotype in the Caucasian Europeans again corresponded to a ratio of approx-
imately 1:2:1 for the I/I, I/D and D/D genotype, respectively. In comparison, a significantly 
higher frequency of the D allele was found in Afro-Caribbean people. In the United Kingdom, 
Sagnella et al. (1999) determined the ACE I/D genotype of a total of 1577 women and men. 
The investigated population consisted of 462 Caucasians, 462 Africans and 442 South Asians. 
The ACE I/D genotype frequency of the Caucasians and Africans was similar. However, the 
frequency of the I/I genotype was significantly higher in the South Asians. 
 
1.2 The ACE I/D genotype and ACE concentration in the blood serum 
It has been shown that the ACE I/D genotype correlates with the ACE concentration in blood 
serum. There is again evidence that this depends on ethnic origin. For example, Rigat et al. 
(1990) found that the ACE I/D genotype explained 47 % of the total phenotypic variance of 
blood serum ACE levels in 80 healthy Caucasians and that carriers of the I/I genotype showed 
the lowest and carriers of the D/D genotype showed the highest ACE concentration in blood 
serum (I/I: 299.3 ± 49.0 µg∙L-1, I/D: 392.6 ± 66.8 µg∙L-1, D/D: 494.1 ± 88.3 µg∙L-1). Further-
more, in a study by Agerholm-Larsen, Tybjaerg-Hansen, Schnohr, and Nordestgaard (1999), 
in which a much larger study population was investigated (n = 869), the ACE I/D genotype 
explained 30-40 % of the total variation of ACE activity in blood serum in Scandinavian Cau-
casians. On the contrary, in Kenyans (Scott et al., 2005) the ACE I/D genotype explained 13 
% and in Pima Indians (Foy et al., 1996) only 6.5 % of  ACE activity in the blood serum. Fur-
thermore, neither African Americans (Bloem, Manatunga, & Pratt, 1996) nor black South 
Africans (Payne et al., 2007) have shown any correlation between ACE I/D genotype and 
ACE activity in blood serum. According to Woods (2009) it can therefore be assumed that 
there are ethnic differences in the transcriptional regulation of ACE. Nevertheless, the ACE 
I/D genotype is an important and consistent marker for ACE activity in blood serum in differ-
ent Caucasian populations, with the ACE concentration being consistent lowest in carriers of 
the I/I genotype, intermediate in carriers of the I/D genotype and highest in carriers of the 
D/D genotype (Woods, 2009). 
 
1.3 ACE within the renin-angiotensin system 
ACE plays an important role within the renin-angiotensin system. The renin-angiotensin sys-
tem is an important control system for the blood pressure and fluid balance of the body 
(Sparks, Crowley, Gurley, Mirotsou, & Coffman, 2014). Within the renin-angiotensin system, 
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ACE produces the vasoactive Angiotensin II by cleaving 2 amino acids from the c-terminus 
of the inactive Angiotensin I (Corvol, Williams, & Soubrier, 1995). Angiotensin II further 
binds to specific angiotensin receptors to trigger a broad range of biological actions including 
vasoconstriction (A. Jones & Woods, 2003; Sparks et al., 2014). ACE also catalyses the inac-
tivation of bradykinin, which is a potent vasodilator (A. Jones & Woods, 2003). In summary, 
ACE simultaneously produces the potent vasoconstrictor Angiotensin II and inactivates the 
potent vasodilator bradykinin (A. Jones & Woods, 2003). 
 
1.4 The ACE I/D genotype and its associations with physical performance 
Over the last 20 years, many studies have been published showing an association between the 
ACE I/D genotype and human physical performance. In general, the I allele has been associ-
ated with increased endurance performance, while the D allele has been associated with in-
creased strength and power performance (Puthucheary et al., 2011).  
One of the first studies showing an association between the ACE I/D genotype and physical 
performance was a study by Montgomery et al. (1997). The authors investigated whether 
there was an association between the ACE I/D genotype and the left ventricular hypertrophy 
in Caucasian military recruits in response to training. They found that a higher left ventricular 
hypertrophy resulted in carriers of the D/D genotype than in carriers of the I/I genotype. In 
addition, Montgomery et al. (1998) investigated the association between the ACE I/D geno-
type and physical performance in two parallel experiments. In the first experiment, they in-
vestigated 33 British elite mountaineers which were able to ascend beyond 7’000 m without 
using supplementary oxygen. They found, that among the 15 climbers who had successfully 
ascended beyond 8’000 m without using supplementary oxygen, none was carrier of the D/D 
genotype. Furthermore, they stated that the top performer was carrier of the I/I genotype. In a 
second experiment, they determined the ACE I/D genotype in 123 Caucasian British army 
recruits of which 78 completed an identical ten-week basic training program. Before and after 
the training period they assessed the maximum duration in which the recruits could perform 
repetitive elbow flexion while holding a 15 kg barbell. Pre-training performance was not de-
pendent on the ACE I/D genotype. After the basic training program the exercise duration im-
proved significantly for the recruits with the I/I and I/D genotype. This was not the case for 
the carriers of the D/D genotype. After these initial studies, there were many other studies, 
especially cross-sectional studies, which investigated the association between the ACE I/D 
genotype and physical performance. 
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1.4.1 Cross sectional studies and the ACE I/D genotype. Gayagay et al. (1998) investigated 
the ACE I/D genotype frequency of 64 Australian national rowers. The authors found an ex-
cess of the I allele in the rowers group when compared with a normal population. In addition, 
Myerson et al. (1999) examined the ACE I/D genotype distribution in 91 British Olympic-
standard runners. The investigated group included runners competing in distances ranging 
from 100 m (sprinters) to 100 km (ultramarathon runners). In this case the authors found that 
the I allele frequency increased with running distance. In a study by Alvarez et al. (2000) the 
ACE I/D genotype was determined in 60 professional athletes (25 cyclists, 20 long-distance 
runners, and 15 handball players) and in 400 control participants. It could be shown that the I 
allele occurred in a significantly higher frequency in the group of elite athletes compared to 
the control group. Similarly, Woods et al. (2001) determined the ACE I/D genotype in 56 elite 
Caucasian swimmers from the European and Commonwealth championships and in 47 non-
elite swimmers from an American college standard team. The authors compared the deter-
mined allele frequencies with several control groups. They found that there was a significant 
excess of the D allele in the elite swimmers when compared to the control group. Further-
more, this association remained in the short distance swimmers (< 400 m) but not in the 
swimmers competing over longer distances (> 400 m). Moreover, Nazarov et al. (2001) de-
termined the ACE I/D genotype in 217 Russian athletes (swimmers, skiers, triathletes and 
track-and-field participants). In this case, the authors divided the athletes in distinct groups 
based on the physical performance (outstanding or average) and the duration of the event 
(short, middle or long distance). They found an excess of the D allele in the outstanding short 
distance athletes and an excess of the I allele in the outstanding middle distance athletes 
group. Collins et al. (2004) determined the ACE I/D genotype in 447 triathletes and in 199 
male control subjects. The examined triathletes had completed the South African Ironman 
Triathlon either in 2000 or 2001. The authors found that there was a significantly higher I 
allele frequency in the 100 fastest triathletes compared to the 166 South Africa-born control 
subjects. Tsianos et al. (2004) hypothesized that the I allele frequency is elevated in swim-
mers competing over longer distances. To investigate this they formed two groups. The first 
group consisted of short long-distance swimmers (5-10 km) and the second group of long 
long-distance swimmers (25 km). It could be shown that there was a significant difference in 
the ACE I/D genotype frequency between the two groups. Juffer et al. (2009) determined the 
ACE I/D genotype in 54 professional footballers. The results of the football players were 
compared with those of 52 male elite endurance athletes and those of 123 inactive healthy 
control subjects. The authors found a higher frequency of the I/D genotype and a lower fre-
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quency of the I/I genotype among footballers compared to the elite endurance athletes. Wang 
et al. (2013) investigated whether the ACE I/D genotype is associated with the elite swimmer 
status. The cohort consisted of 200 elite Caucasian swimmers from Europe, the Common-
wealth, Russia and America and 326 elite swimmers of Japanese and Taiwanese origin. The 
authors found that the ACE I/D genotype was associated with the swimmer status in the group 
of Caucasian. The D allele was overrepresented in the short and medium distance swimmers. 
In addition, the ACE I/D genotype was associated with the swimmer status in the group of 
East Asian countries. In this group, however, the I allele was overrepresented among the 
short-distance swimmers. In addition, Papadimitriou et al. (2016) have shown that the ACE 
I/D genotype may influences sprint performance. The authors collected the personal best 
times in the disciplines 100, 200 and 400 m of elite sprinters from ten different countries 
(Caucasian and sprinters of African origin). They found that Caucasian sprinters with the D/D 
genotype performed better on average over 200 and 400 m than sprinters with the I/I geno-
type. 
 
1.4.2 No association between ACE I/D genotype and physical performance. It is notewor-
thy to mention that there are also studies that have not found an association between the ACE 
I/D genotype and physical performance. For example, Taylor, Mamotte, Fallon, and van 
Bockxmeer (1999) compared the ACE I/D genotype frequency of 120 Caucasian athletes 
from different national teams of Australia with a control group of healthy subjects. The au-
thors only included sports, which demand a high level of aerobic fitness such as cycling, track 
and field, swimming and rowing. In this study, they found no significant difference between 
the investigated groups. In addition, Karjalainen et al. (1999) investigated whether the left 
ventricular mass in athletes was associated with genes that encode renin-angiotensin system 
components. The authors measured the left ventricular mass and determined the ACE I/D 
genotype of 50 male and 30 female elite endurance athletes. They found no association be-
tween the ACE I/D genotype and left ventricular mass. Furthermore, Rankinen et al. (2000) 
compared the ACE I/D genotype of 192 male endurance athletes who had a peak oxygen up-
take (VO2peak) ≥ 75 mL∙min
-1∙kg-1 with 189 inactive male control subjects. Both the genotype 
frequency and the allele frequency were not significantly different between the two investi-
gated groups. Further analyses showed no overrepresentation of the I allele in athletes with 
the highest VO2peak (> 80 mL∙min
-1∙kg-1). This finding is supported by the results of the study 
by Sonna et al. (2001), in which the authors determined the ACE I/D genotype in 85 female 
and 62 male US Army recruits. In addition, they determined the VO2peak before and after eight 
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weeks of basic training as well as standardized measurements of muscular endurance (sit-ups 
and push-ups) and a two-mile run within the Army Physical Fitness Test. The VO2peak of the 
three ACE I/D genotype groups (I/I vs. I/D vs. D/D) did not differ significantly either before 
or after the basic training. Subjects carrying the I/I genotype achieved better results in Army 
Physical Fitness Test, but not to a significant extent. Similarly, Woods et al. (2002) found no 
association between the VO2peak of 58 army recruits and the ACE I/D genotype. In this study, 
the authors tested the VO2peak before and after 11 weeks of identical training. There was no 
significant difference between the I/I genotype and the D/D genotype before and after train-
ing. Therefore, the authors concluded that associations between ACE I/D polymorphism and 
increased endurance performance are not due to differences in the cardiorespiratory response 
to training. Interestingly, Interestingly, Bueno et al. (2016) investigated the influence of the 
ACE I/D genotype on markers of aerobic fitness. The authors examined the VO2peak, aerobic 
capacity and running efficiency of 150 physically active young men. The VO2peak and the aer-
obic capacity were measured using an incremental treadmill test. In order to determine run-
ning efficiency, two constant speed tests were carried out. None of the cardiorespiratory vari-
ables showed a significant association. Only a tendency towards higher VO2peak in the I/I gen-
otype compared to the I/D and DD genotype could be shown. A recent study by 
Papadimitriou et al. (2018) also found no association between the ACE I/D genotype and run-
ning times of 698 Caucasian endurance athletes from six countries (United Kingdom, Italy, 
Poland, Greece, Russia and Australia). The authors collected a total of 1064 personal best 
times in the disciplines 1’500, 3’000, 5’000 m and marathon. They did not find any associa-
tion with the ACE I/D genotype in any of the disciplines. 
The studies listed above show that the lack of association to the ACE I/D genotype is often 
associated with the measurement of whole-body VO2peak. On the contrary, studies which have 
focused on skeletal muscle had more success in finding associations to the ACE I/D genotype. 
 
1.4.3 Skeletal muscle studies and the ACE I/D genotype. Williams et al. (2000) investigat-
ed the efficiency of muscular contraction in 58 male Caucasian recruits before and after elev-
en-week of a primarily aerobic training program. In order to measure the efficiency of muscu-
lar contraction, the authors measured the steady-state VO2 and the respiratory exchange ratio 
while the subjects were pedalling on a bicycle ergometer with a constant pedal cadence of 60 
rpm for three minutes on three successive external power output stages (40, 60 and 80 W). 
Delta efficiency was defined as the percentage of the ratio of the change in the amount of 
work done per minute to the change in the energy expended per minute. Before the training, 
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delta efficiency was independent of genotype. After the training, however, delta efficiency 
was strongly genotype-dependent, whereby delta efficiency improved significantly only in 
carriers of the I/I genotype. The authors hypothesized that the relationship between the I/I 
genotype and the improved efficiency of exercising muscles is probably related to an increase 
in slow-twitch type I muscle fibres. Interestingly, Zhang et al. (2003) investigated the associa-
tion between the ACE I/D genotype and skeletal muscle fibre types in 41 untrained healthy 
subjects. The authors found that carriers of the I/I genotype had a significantly higher per-
centage of slow-twitch type I fibres than carriers of the D/D genotype. Other authors who 
investigated the association between the ACE I/D genotype and the cellular and molecular 
properties of the skeletal muscle were also successful. For example, Vaughan et al. (2013) 
found that carriers of the I/I and I/D genotype showed a significantly higher mitochondrial 
density, intracellular lipid volume and a stronger expression of genes that are important in the 
metabolism of fatty acids as an adaption to endurance exercise when compared to carriers of 
the D/D genotype. In addition, Vaughan et al. (2016) investigated the association between the 
ACE I/D genotype and the changes of exercise-induced capillarisation of the skeletal muscle. 
The study examined 52 non-specifically trained Caucasian men who had either completed a 
one-legged cycling test until volitional fatigue and or participated in a marathon. The authors 
found that the capillary-to-fibre ratio in the m. vastus lateralis was higher for carriers of the 
I/I and I/D genotype than for carriers of the D/D genotype. Recently, Valdivieso et al. (2017) 
investigated the influence of ACE I/D genotype, endurance training status and its interaction 
on metabolic and angiogenic adaptations in the m. vastus lateralis. The authors examined 34 
endurance trained (VO2peak > 50 mL∙min
-1∙kg-1) and 18 untrained (VO2peak < 50 mL∙min
-1∙kg-1) 
male Caucasians who had performed a one-legged cycling test until volitional fatigue. They 
found that the capillary density and the capillary-to-fibre ratio were dependent on the ACE 
I/D genotype. Furthermore, interaction effects of the ACE I/D genotype and endurance train-
ing status on the cross-sectional area (CSA) and mean cross-sectional area (MCSA) of slow-
twitch type I fibres of the m. vastus lateralis were found. Untrained carriers of the I allele had 
a larger CSA than untrained non-carriers of the I allele. Furthermore, trained I allele carriers 
showed a larger slow-twitch type I MCSA than trained non-carriers of the I allele.   
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Based on these results, it could be concluded that the influence of ACE I/D genotype is more 
likely to be found on a skeletal muscle level. In order to answer the research questions con-
cerning cellular and molecular skeletal muscle characteristics, the invasive intervention of the 
muscle biopsy is necessary. Since this is a cost-intensive and invasive procedure, this inter-
vention is difficult to implement, especially in professional sports. Fortunately, there are also 
non-invasive techniques to investigate skeletal muscle characteristics. Interestingly, muscle 
monitors based on near-infrared spectroscopy (NIRS) offer the possibility of non-invasive 
measurement of skeletal muscle oxygenation during exercise. 
 
1.5 The use of NIRS to study skeletal muscle oxygenation 
NIRS for monitoring muscle tissue oxygenation was first described by Jobsis (1977). Since 
then, NIRS has been used to investigate muscle oxidative metabolism at rest and during dif-
ferent types of exercise (Ferrari, Muthalib, & Quaresima, 2011). A simple NIRS device con-
sists of a light source in the near-infrared (650-1000 nm) range, which emits light of mini-
mum two different wavelengths and a detector (S. Jones, Chiesa, Chaturvedi, & Hughes, 
2016). NIRS is based on the principle that absorption of near-infrared light differs from oxy-
genated and deoxygenated haemoglobin and myoglobin (S. Jones et al., 2016). Therefore, 
muscle oxygen monitors using the NIRS technique offer the possibility of non-invasive meas-
urement of muscle oxygen saturation (SmO2). SmO2 represents the dynamic balance between 
O2 supply and O2 consumption of the examined muscle (Ferrari et al., 2011). NIRS devices 
have been used to measure muscle deoxygenation during exercise as well as the reoxygena-
tion kinetics after exercise. The muscle deoxygenation during exercise is mainly dependent on 
the O2 consumption of mitochondria (Muthalib, Millet, Quaresima, & Nosaka, 2010). The 
reoxygenation kinetics has been shown to correlate with muscle oxidative capacity (Puente-
Maestu et al., 2003)  
During an incremental cycle ergometer test (ramp test) it could be shown that the SmO2 de-
creased progressively and reached its physiological minimum when VO2peak was reached 
(Belardinelli, Barstow, Porszasz, & Wasserman, 1995). Moreover, it has been shown that 
gender (Murias, Keir, Spencer, & Paterson, 2013), endurance training status (Boone, Koppo, 
Barstow, & Bouckaert, 2009) and different training modalities (Jacobs et al., 2013; Takagi et 
al., 2016) influences muscle deoxygenation during ramp test. In addition, studies have shown 
that the reoxygenation kinetics depends on the endurance training status (Ding et al., 2001) 
and changes with training (Puente-Maestu et al., 2003).   
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In the context of the ACE I/D genotype, it has been shown that the D/D genotype is associat-
ed with an impairment of peripheral tissue oxygenation in patients with chronic obstructive 
pulmonary disease (COPD) (Kanazawa, Otsuka, Hirata, & Yoshikawa, 2002). However, to 
date, to my knowledge, no study has investigated the individual and combined effects of the 
ACE I/D genotype and endurance training status on SmO2 markers during a ramp test in 
healthy subjects using a non-invasive NIRS device. 
 
1.6 Objective 
The aim of this study is to find out whether there are individual and combined effects of the 
ACE I/D genotype and endurance training status on SmO2 markers during a ramp test. On 
account of this, the following specific research questions were formulated: 
 
a) Is there an effect of the ACE I/D genotype on SmO2 markers during a ramp test? 
b) Is there an effect of the endurance training status on SmO2 markers during a ramp test 
c) Is there an interaction effect between the ACE I/D genotype and the endurance training 
status on SmO2 markers during a ramp test?  
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2 Methods 
2.1 Study design 
 
Figure 1. Study design. All subjects (N = 21) performed a ramp test and were genotyped for the ACE gene I/D 
polymorphism. For statistical analysis subjects were grouped according to endurance training status and ACE 
I/D genotype. Ramp test = incremental cycle ergometer test, VO2peak = peak oxygen uptake, SmO2 = muscle 
oxygen saturation, Trained = VO2peak > 50 mL∙min
-1∙kg-1, Untrained = VO2peak < 50 mL∙min
-1∙kg-1, ACE = angio-
tensin-converting enzyme, I/D = insertion/deletion.  
 
The present study was a cross-sectional study in which the subjects performed a ramp test and 
were genotyped for the ACE gene I/D polymorphism (Figure 1). Prior to the ramp test, the 
anthropometric data (weight and height) of the subjects were collected. The ramp test was 
used to measure whole-body VO2peak and the SmO2 of the knee extensor muscle m. vastus 
lateralis. VO2peak was used to differentiate between those who were endurance trained 
(Trained: VO2peak > 50 mL∙min
-1∙kg-1) and those who were endurance untrained (Untrained: 
VO2peak < 50 mL∙min
-1∙kg-1) as described by Valdivieso et al. (2017). Genotyping was per-
formed retrospectively. 
  
Sample (N = 21)
Genotyping
ACE gene I/D polymorphism
I/I I/D D/D
Ramp test
Anthropometric data measurement
VO2peak measurement
SmO2 measurement
Trained Untrained
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2.2 Subjects 
21 non-specific trained women and men were recruited for the present study (Table 1). The 
inclusion criteria were as follows: a) healthy; b) cardiovascular unobtrusive; c) at the age of 
20-70 years. After being informed about the objective and the protocol of the study, all sub-
jects signed a declaration of consent (see Appendix). In order to ensure that they were physi-
cally healthy to pass the test, they completed a health questionnaire (see Appendix). In addi-
tion, a resting electrocardiography measurement was performed and checked by a physician 
for cardiovascular abnormalities. The study has been approved by the Ethics Committee of 
the Canton of Zurich. All investigations were conducted in accordance with the ethical stand-
ards of the Declaration of Helsinki of 1964.   
 
Table 1 
Anthropometric data of the subjects (N = 21) 
Age in [years] Weight in [kg] Height in [m]  BMI in [kg/m
2
] 
Female (n = 9)    
25.67 ± 4.67 63.50 ± 7.66 1.67 ± 0.06 22.71 ± 1.99 
Male (n = 12)    
28.08 ± 4.17  76.84 ± 5.32 1.80 ± 0.05 23.82 ± 2.17 
Note. Anthropometric data are presented as mean ± standard deviation. 
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2.3 Ramp test 
The ramp test was performed on an electrically braked cycle ergometer (ergoselect 200, ergo-
line, Bitz, Germany) in an air-conditioned laboratory (Figure 2). To determine the VO2peak the 
gas exchange was measured with a breath-by-breath system (meta control 3000, Cortex, 
Leibzig, Germany). All Subjects performed the test in an upright sitting position on a self-
paced pedal cadence in the range of 70 to 100 rpm. The ramp test protocol corresponded to a 
modified version of the protocol of Whipp, Davis, Torres, and Wasserman (1981). After a 
three-minute pre-rest period, in which the subjects had to sit on the cycle ergometer without 
moving the pedals, the initial power (75 W for women and 100 W for men) was increased 
every 20 s (18 W∙min-1 for women and 30 W∙min-1 for men). The test was stopped if volition-
al fatigue was reached or until the target pedal cadence could not be longer maintained. After 
the test stoppage, there was an additional eight-minute post-rest period, in which the subjects 
had to sit on the cycle ergometer without moving the pedals. 
 
 
Figure 2. Incremental cycle ergometer test (ramp test) equipment. VO2 = oxygen uptake, SmO2 = muscle oxygen 
saturation. 
  
VO2 measurement
SmO2 measurement
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2.4 NIRS measurement 
A muscle oxygen monitor (Moxy, Fortiori Design LLC, Minnesota, United States), based on 
the technology of NIRS, was used to measure SmO2 non-invasively. The Moxy Monitor uses 
four different light sources covering wavelengths in the range from 630 to 850 nm and the 
Beer-Lambert law to perform quantitative measurements of SmO2 (Fortiori Design, 2015). 
SmO2 refers to the percentage of haemoglobin and myoglobin that have bound oxygen in ca-
pillaries of the investigated muscle (Fortiori Design, 2015). SmO2 is calculated with the fol-
lowing formula: 
 
𝑆𝑚𝑂2 = (
𝑂𝑥𝑦𝑔𝑒𝑛𝑎𝑡𝑒𝑑 ℎ𝑎𝑒𝑚𝑜𝑔𝑙𝑜𝑏𝑖𝑛 + 𝑚𝑦𝑜𝑔𝑙𝑜𝑏𝑖𝑛
𝑇𝑜𝑡𝑎𝑙 𝑎𝑚𝑜𝑢𝑛𝑡 𝑜𝑓 ℎ𝑎𝑒𝑚𝑜𝑔𝑙𝑜𝑏𝑖𝑛 + 𝑚𝑦𝑜𝑔𝑙𝑜𝑏𝑖𝑛
) ∙ 100 
 
The Moxy Monitor was placed on the m. vastus lateralis of the left leg of the subjects. The 
sensor was placed 10 cm above the upper lateral point of the patella along the axis of the leg 
(Figure 3). Prior to the placement, the skin site was shaved using a disposable razor (Gallant, 
Dynarex, Orangeburg, United States) and cleaned with an alcohol swab (Webcol™, 
Covidien™, Dublin, Ireland). The sensor attachment was carried out using an attachment tape 
(Moxy Adhesive Attachments, Fortiori Design LLC, Minnesota, United States). In order to 
protect the NIRS device from ambient light it was covered with an adhesive non-woven fabric 
(Hypafix®, BSN medical, Hamburg, Gerrmany). 
 
 
Figure 3. Moxy monitor placement. The 
sensor was placed 10 cm above the upper 
lateral point of the patella along the axis 
of the leg.  
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2.5 Genotyping 
Genomic DNA (gDNA) was collected by buccal swabs. The subjects were told not to con-
sume any food or to drink in the 30 min prior to gDNA collection to avoid contamination of 
the sample. To collect the gDNA sample, the buccal swab was firmly scraped against the in-
side of each cheek six times. After collection the buccal swab was air-dried in a laboratory 
fume cupboard (Secuflow 1500, Waldner, Wangen, Germany) for 2 hours and stored at + 4 
°C. 
gDNA extraction procedure was performed according to a commercially available protocol 
(QIAamp
®
 DNA Mini Kit, Qiagen, Hilden, Germany). The cotton swab was separated from 
the stick with scissors, placed in a 2 mL micro centrifuge tube and 400 µL of phosphate-
buffered saline buffer solution was added. Degradation of ribonucleic acid (RNA) was per-
formed by adding 4 µL of RNase A stock solution (100 mg∙mL-1) to solution. Lysis was fur-
ther carried out by adding 20 µL QIAGEN
®
 proteinase K stock solution and 400 µL Buffer 
AL. The lysis mix was mixed immediately for 15 s and incubated at 56 °C for 10 min using a 
digital dry bath (AccuBlock
™
, Labnet International, Edison, United States). After incubation 
400 µL of ethanol (96-100 %) was added to the sample and mixed again. The mixture was 
then applied to the QIAamp Mini spin column and placed in a 2 mL collection tube. To bind 
gDNA, the closed columns were centrifuged at 8000 rpm for 1 min using an air-cooled micro 
centrifuge (Prism™, Labnet International, Edison, United States). The QIAamp Mini spin 
column was then placed in a clean 2 mL collection tube and the tube containing the filtrate 
was discarded. The remaining mixture was added to the QIAamp Mini spin column and again 
centrifuged at 8000 rpm for 1 min. Washing was carried out in two steps. First, 500 µL AW1 
buffed was added and centrifuged at 8000 rpm for 1 min. Second, 500 µL of AW2 buffer was 
added and centrifuged at full speed (14’000 rpm) for 3 min. In order to elute the DNA, 75 µL 
AE buffer was added, incubated at room temperature (20 °C) for 1 min, and then centrifuged 
at 8000 rpm for 1 min. This step was performed twice to increase the DNA yield. The sample 
(150 µL elute containing the gDNA) was then stored at + 4 °C for the genotyping step.  
18 
ACE I/D gene polymorphism genotyping was carried out through polymerase chain reaction 
(PCR) followed by high resolution melt (HRM) analysis using a real-time PCR system (Eco
™
, 
illumina
®
, San Diego, United States). The reaction mix included for one sample 1 µL distilled 
H2O, 1 µL of MgCl2 (25 mmol), 5 µL of KAPA HRM FAST Master Mix (2x) and 1 µL of the 
I or D allel-specific primer mix (2 µmol). The primer mix for the detection of the 66 bp am-
plicon, which is specific to the I allele, contained the primer ACE2 (5’-
tgggattacaggcgtgatacag-3’) and the primer ACE3 (5’atttcagagctggaataaaatt-3’). The primer 
mix for the detection of the 83 bp amplicon, which is specific to the D allele, contained pri-
mers ACE1 (5’-catcctttctcccatttctc-3’) and ACE3 (5’atttcagagctggaataaaatt-3’). 8 µL of the 
reaction mix were pipetted into each well of the 48 well-plate and 2 µL of the prepared gDNA 
solution was added. The plate was then sealed to prevent evaporation. To remove any bubbles 
the plate was centrifuged. PCR and HRM were performed with the Eco
™
 machine settings 
shown in Table 2. Genotype analysis was carried out using a genetic variation analysis soft-
ware (EcoStudy Version 5.0, illumina
®
, San Diego, United States). 
 
Table 2 
Eco
™
 machine settings 
Step Temperature Duration  Cycle 
Enzyme activation 95 °C 3 min Hold 
Denaturation 95 °C 5 s 
40 
Annealing-Extension 60 °C 30 s 
HRM Denaturation 95 °C 1 min Hold 
HRM 55 °C 15 s - 
HRM 95 °C 15 s - 
Note. Eco
™
 machine settings. HRM = high resolution melt. 
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2.6 Data processing 
 
Figure 4. Representative example of the SmO2 course during the ramp test including raw data, 
processed data and different markers. SmO2 = muscle oxygen saturation, t = time, min = mini-
mum, max = maximum. 
 
A representative example of the SmO2 course during the ramp test including raw data, pro-
cessed data and different markers is shown in Figure 4. Data pre-processing and analysis was 
performed using a data processing program (MATLAB 2015a, The Mathworks, Natick, Unit-
ed States). SmO2 data was filtered using a 2
nd
 order zero-phase shift Butterworth low-pass 
filter with a cut-off frequency of 0.03 Hz. Data extraction was performed based on the de-
scription of NIRS signal interpretation by Ferrari et al. (2011). SmO2 baseline represented the 
mean value of the three-minute pre-rest period. The minimum SmO2 value during the ramp 
test (SmO2 min) was extracted by taking the last local minimum of the filtered SmO2 prior to 
reoxygenation. ∆deoxygenation was the difference between SmO2 baseline and SmO2 min. tdeoxygenation 
was the time from the beginning of the ramp test until SmO2 min was reached. slopedeoxygenation 
was calculated using ∆deoxygenation over tdeoxygenation. SmO2 max was defined as the highest value 
achieved within the period between the start of reoxygenation and test termination. SmO2 1/2 
reoxygenation was defined as 50 % of the difference between SmO2 max and SmO2 min. ∆1/2 reoxygena-
tion was the difference between SmO2 1/2 reoxygenation and SmO2 min. t1/2 reoxygenation was defined as 
the time between SmO2 min and SmO2 1/2 reoxygenation. Slope 1/2 reoxygenation was calculated using 
∆1/2 reoxygenation over t1/2 reoxygenation. SmO2 overshoot represented the difference between SmO2 max 
and SmO2 baseline.    
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2.7 Statistical analysis 
An online calculator from Rodriguez, Gaunt, and Day (2009) was used in order to determine 
whether the observed genotype frequency is consistent with the Hardy-Weinberg equilibrium 
(HWE). To determine genotype-specific differences in SmO2 markers during the ramp test, a 
codominant genetic model was selected (I/I vs. I/D vs. D/D). The statistical analysis was per-
formed using statistical software (SPSS Statistics 22, IBM, Armonk, United States). To exam-
ine the variance homogeneity Levene test was carried out. Two factor analysis of variance 
(ANOVA) was used to investigate the individual and combined effects of the ACE I/D geno-
type and endurance training status on SmO2 markers during ramp test. Least significant dif-
ference (LSD) of Fisher was used as a post hoc test. The significance levels were determined 
as follows: p > 0.05 = not significant, p < 0.05 = significant and p < 0.01 = highly significant. 
The effect size d was calculated according to Cohen (1992) and defined as follows: d = 0.20 = 
small effect, d = 0.50 = medium effect, d = 0.80 = large effect. All data are presented as mean 
± standard deviation.   
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3 Results 
3.1 No individual effect of the ACE I/D genotype on SmO2 during ramp test 
 
Figure 5. No individual effect of the ACE I/D genotype on SmO2 markers during ramp test. Bar graphs represent 
mean ± standard deviation of extracted SmO2 markers grouped by the ACE I/D genotype. Details of SmO2 mark-
er extraction are presented in section 2.6 Data processing. SmO2 = muscle oxygen saturation, ACE = angioten-
sin-converting enzyme, I/D = insertion/deletion. I/I (n = 8), I/D (n = 10), D/D (n = 3). 
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ACE I/D genotype-grouped mean ± standard deviation values of the extracted SmO2 markers 
are shown in Figure 5. The ACE I/D genotype alone did not have a significant effect on any 
of the extracted SmO2 markers during ramp test. Individual F and p values are shown in Table 
3 (see Appendix). 
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3.2 Effects of the endurance training status on SmO2 during ramp test 
 
Figure 6. Effects of the endurance training status on SmO2 markers during ramp test. Bar graphs represent mean 
± standard deviation of extracted SmO2 markers grouped by the endurance training status. Details of SmO2 
marker extraction are presented in section 2.6 Data processing. SmO2 = muscle oxygen saturation, Trained = 
VO2peak > 50 mL∙min
-1∙kg-1, Untrained = VO2peak < 50 mL∙min
-1∙kg-1. Trained (n = 9), Untrained (n = 12). * indi-
cates p < 0.05, ** indicates p < 0.01. 
T
ra
in
e
d
U
n
tr
a
in
e
d
0
2 0
4 0
6 0
8 0
S m O 2 b a s e l in e
tra in in g  s ta tu s
S
m
O
2
 i
n
 [
%
]
T
ra
in
e
d
U
n
tr
a
in
e
d
0
2 0
4 0
6 0
S m O 2  m in
tra in in g  s ta tu s
S
m
O
2
 i
n
 [
%
]
*
T
ra
in
e
d
U
n
tr
a
in
e
d
-6 0
-5 0
-4 0
-3 0
-2 0
-1 0
0
 d e o x y g e n a t io n
tra in in g  s ta tu s
S
m
O
2
 i
n
 [
%
]
*
T
ra
in
e
d
U
n
tr
a
in
e
d
0
2 0 0
4 0 0
6 0 0
8 0 0
td e o x y g e n a t io n
tra in in g  s ta tu s
ti
m
e
 i
n
 [
s
]
T
ra
in
e
d
U
n
tr
a
in
e
d
-0 .1 0
-0 .0 8
-0 .0 6
-0 .0 4
-0 .0 2
s lo p e d e o x y g e n a t io n
tra in in g  s ta tu s
s
lo
p
e
 i
n
 [

d
e
o
x
y
g
e
n
a
t
io
n
 
s
-1
]
T
ra
in
e
d
U
n
tr
a
in
e
d
0
2 0
4 0
6 0
8 0
1 0 0
S m O 2  m a x
tra in in g  s ta tu s
S
m
O
2
 i
n
 [
%
]
T
ra
in
e
d
U
n
tr
a
in
e
d
0
2 0
4 0
6 0
8 0
 1 /2  r e o x y g e n a t io n
tra in in g  s ta tu s
S
m
O
2
 i
n
 [
%
]
* *
T
ra
in
e
d
U
n
tr
a
in
e
d
0
2 0
4 0
6 0
8 0
t1 /2  r e o x y g e n a t io n
tra in in g  s ta tu s
ti
m
e
 i
n
 [
s
]
T
ra
in
e
d
U
n
tr
a
in
e
d
0 .0
0 .5
1 .0
1 .5
s lo p e 1 /2  r e o x y g e n a t io n
tra in in g  s ta tu s
s
lo
p
e
 i
n
 [

1
/2
 r
e
o
x
y
g
e
n
a
t
io
n
 
s
-1
]
T
ra
in
e
d
U
n
tr
a
in
e
d
0
1 0
2 0
3 0
4 0
S m O 2  o v e r s h o o t
tra in in g  s ta tu s
S
m
O
2
 i
n
 [
%
]
24 
Endurance training status-grouped mean ± standard deviation values of the extracted SmO2 
markers are shown in Figure 6. There was a significant effect of the endurance training status 
on the marker SmO2 min (p = 0.017) and ∆deoxygenation (p = 0.033). The SmO2 min was on average 
lower for the trained subjects compared to untrained subjects (25.24 ± 6.94 vs. 37.74 ± 7.86 
%, respectively). ∆deoxygenation was on average higher in trained than in untrained subjects (-
34.72 ± 10.70 vs. -22.81 ± 9.25 %, respectively). In addition, there was a highly significant 
effect of the endurance training status on the marker ∆1/2 reoxygenation (p = 0.007). Trained sub-
jects showed a higher ∆1/2 reoxygenation than untrained subjects (56.22 ± 7.22 vs. 35.54 ± 12.36 
%, respectively).The effect sizes for the markers SmO2 min (d = 0.70) and ∆deoxygenation (d = 
0.61) are to be classified as medium and for ∆1/2 reoxygenation (d = 0.80) as large (Cohen, 1992). 
In all other SmO2 markers no significant effect of the endurance training status was found.  
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3.3 Interaction effect between the ACE I/D genotype and endurance training status 
 
Figure 7. Interaction effect between the ACE I/D genotype and endurance training status on slopedeoxygenation. Bar 
graphs represent mean ± standard deviation of the marker slopedeoxygenation grouped by the ACE I/D genotype and 
endurance training status. Only the SmO2 marker is shown in which a significant interaction effect of ACE I/D 
genotype and endurance training status was found. Details of SmO2 marker extraction are presented in section 
2.6 Data processing. SmO2 = muscle oxygen saturation, Trained = VO2peak > 50 mL∙min
-1∙kg-1, Untrained = 
VO2peak < 50 mL∙min
-1∙kg-1. * indicates p < 0.05, ** indicates p < 0.01. 
 
Mean ± standard deviation values of the marker slopedeoxygenation grouped by ACE I/D geno-
type and endurance training status are shown in Figure 7. There was a significant interaction 
effect between ACE I/D genotype and endurance training status on the marker slopedeoxygenation 
(p = 0.028). The effect size (d = 0.78) is to be classified as medium according to Cohen 
(1992). Pairwise comparisons revealed that trained carriers of the I/I genotype showed a high-
ly significant steeper slopedeoxygenation (p = 0.003) than untrained carriers of the I/I genotype (-
0.081 ± 0.012 vs. -0.035 ± 0.012 ∆deoxygenation∙s
-1
, respectively). In addition, untrained carriers 
of the I/D genotype showed a significantly steeper slopedeoxygenation (p = 0.017) than untrained 
carriers of the I/I genotype (-0.065 ± 0.014 vs. -0.035 ± 0.012 ∆deoxygenation∙s
-1
, respectively). In 
all other SmO2 markers no significant interaction effect between ACE I/D genotype and en-
durance training status was found.  
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4 Discussion 
In the present study, the individual and combined effects of the ACE I/D genotype and endur-
ance training status on SmO2 markers during ramp test were investigated by a cross-sectional 
observation. It could be shown that the ACE I/D genotype individually had no significant 
effect on any of the extracted SmO2 markers. The endurance training status, on contrary, had 
a significant effect on SmO2 min and ∆deoxygenation as well as a highly significant effect on ∆1/2 
reoxygenation. Interestingly, a significant interaction between the ACE I/D genotype and endur-
ance training status on the slopedeoxygenation was observed. 
 
4.1 No individual effect of the ACE I/D genotype on SmO2 during ramp test 
The ACE I/D genotype did not have a significant effect on any of the SmO2 markers. This 
result is in contrast to studies which were able to identify associations between the ACE I/D 
genotype and cellular and molecular skeletal muscle characteristics. As it has already been 
shown that the ACE I/D genotype is associated with the percentage of slow-twitch type I fi-
bres (Zhang et al., 2003), mitochondrial density (Vaughan et al., 2013) and capillary density 
as well as capillary-to-fibre ratio (Valdivieso et al., 2017; Vaughan et al., 2016), it could be 
assumed that genotype-specific differences in the SmO2 markers measured with a non-
invasive NIRS could be found. One of the reasons for this result could be the sample hetero-
geneity. In the present study, the investigated sample was non-homogenous in terms of gender 
and endurance training status. According to Woods (2009), one of the main reasons for nega-
tive studies regarding the association of the ACE I/D genotype with physical performance is 
the inclusion of subjects from different sporting disciplines which results in a heterogeneous 
sample. 
Homogeneity is desirable in these genetic performance studies as the ACE gene is only 
one of many genetic factors affecting performance, and the addition of other (non-
genetic factors) such as age, sex and sporting discipline, which may themselves inter-
act with genotype, often results in too great a variance in phenotype to be able to dis-
cern the role of genotype. (Puthucheary et al., 2011, p. 436) 
The assumption that the lack of the ACE I/D genotype effect occurred due to the heterogene-
ous sample is supported by studies that have shown that both gender and endurance training 
status influence SmO2 during ramp test. For example, Murias et al. (2013) found gender-
specific differences in the temporal profile of muscle deoxygenation during a ramp test. Com-
pared to men, young women showed a weaker ability to transport O2 to the working muscle. 
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In addition, it could be shown that endurance training status influences muscle deoxygenation 
during ramp test. In this context, Boone et al. (2009) found out that the aerobic fitness status 
influences muscle deoxygenation during ramp test. The authors compared the m. vastus lat-
eralis deoxygenation of 10 highly trained cyclists with 11 physically active students. They 
found that the sigmoid pattern of deoxygenation in highly trained cyclists is shifted to the 
right compared to physically active students. According to Valdivieso et al. (2017) there are 
indications that regular intensive endurance training and its associated local metabolic effects 
may partly override the influence of the ACE I/D genotype on aerobic muscle performance. 
Therefore, gender and endurance training status can be considered as possible confounders 
and these factors may have eliminated a possible individual effect of the ACE I/D genotype 
on SmO2 markers during ramp test. 
In contrast to the present study, Kanazawa et al. (2002) found an association between the 
ACE I/D genotype and tissue oxygenation in 39 patients with COPD. The ratio between the 
change in oxygen supply to the increase in oxygen uptake was significantly lower in patients 
with the D/D genotype than in those with the I/I genotype. The authors concluded that the 
D/D genotype may be associated with an impairment of peripheral tissue oxygenation. How-
ever, it can be stated that the investigated sample was a specific pathological sample (COPD 
patients) with specific muscular characteristics and thus may not be reflective of healthy sub-
jects. 
 
4.2 Effects of the endurance training status on SmO2 during ramp test  
The endurance training status had a significant effect on the markers SmO2 min (p = 0.017) and 
∆deoxygenation (p = 0.033). During the ramp test, the trained group achieved on average a lower 
SmO2 min value than the untrained group (25.24 ± 6.94 vs. 37.74 ± 7.86 %, respectively). This 
resulted in a higher value for the ∆deoxygenation marker for the trained compared to the untrained 
group (-34.72 ± 10.70 vs. -22.81 ± 9.25 %, respectively). Since the SmO2 baseline value between 
trained and untrained subjects did not differ significantly, it can be concluded that there was a 
greater O2 extraction of the m. vastus lateralis in endurance trained subjects compared to un-
trained subjects. This result is supported by longitudinal studies which have previously shown 
that physical training (and thus the endurance training status) can affect muscle deoxygena-
tion in healthy and diseased subjects. For example, Jacobs et al. (2013) investigated the mus-
cle deoxygenation before and after six sessions of high-intensity interval training (HIIT) in 
healthy subjects. The authors showed that an increase in muscle deoxygenation during ramp 
test resulted after the training phase. In addition, Takagi et al. (2016) investigated the muscle 
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deoxygenation before and after a twelve-week aerobic training period in post-myocardial in-
farction patients. The authors found that aerobic training led to an increased deoxygenation of 
the m. vastus lateralis during ramp test. Furthermore, Okushima et al. (2016) found that a 
greater VO2peak is correlated with greater skeletal muscle deoxygenation amplitude during 
ramp test.  
In addition, there was a highly significant effect of the endurance training status on the marker 
∆1/2 reoxygenation (p = 0.007). It could be shown that trained subjects had a higher ∆1/2 reoxygenation 
than untrained subjects (56.22 ± 7.22 vs. 35.54 ± 12.36 %, respectively). This result is sup-
ported by previous studies which have shown that both endurance training status and training 
can influence the reoxygenation kinetics after exercise. For example, Ding et al. (2001) com-
pared the reoxygenation kinetics after an incremental cycle ergometer test of 18 male elite 
athletes with 8 healthy young men. The authors found that elite athletes showed a significant 
higher half recovery increment of SmO2 compared to the healthy control subjects. In addition, 
Puente-Maestu et al. (2003) investigated the effects of a six-week high work cycle ergometer 
training in COPD patients. The authors investigated the muscle deoxygenation and reoxygen-
ation via NIRS and the change of oxidative enzymes via muscle biopsies. They found that 
training increased the speed of the m. vastus lateralis reoxygenation after exercise and that 
this improvement correlated with the change in several oxidative enzymes. Therefore, the 
higher ∆1/2 reoxygenation found in trained subjects could indicate a greater muscle oxidative ca-
pacity.  
 
4.3 Interaction effect between the ACE I/D genotype and endurance training status 
There was a significant interaction effect between the ACE I/D genotype and endurance train-
ing status on the marker slopedeoxygenation (p = 0.028). Pairwise comparisons revealed that only 
within the I/I genotype there was a highly significant difference in the slopedeoxygention (p = 
0.003) between endurance trained and untrained subjects (-0.081 ± 0.012 vs. -0.035 ± 0.012 
∆deoxygenation∙s
-1
, respectively). Trained carriers of the I/I genotype had a highly significant 
steeper slopedeoxygenation than untrained carriers of the I/I genotype. Within the I/D and the D/D 
genotype there was no significant difference. Therefore, it could be concluded that carriers of 
the I/I genotype may have greater potential to improve in skeletal muscle O2 extraction per 
unit time with training in a hypothetical training scenario. This result seems supported by the 
study by Williams et al. (2000), which showed that only subjects with the I/I genotype were 
able to significantly improve the efficiency of skeletal muscle contractions after training com-
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pared to the I/D and D/D genotype. The authors concluded that this may be associated with an 
increase in slow-twitch type I muscle fibres. Since the deoxygenation of the muscle depends 
mainly on the O2 extraction by the mitochondria (Muthalib et al., 2010), it can be speculated 
that the trained carriers of the I/I genotype had a higher percentage of slow-twitch type I mus-
cle fibres and thus a higher mitochondrial density. In previous studies, it has been shown that 
the I/I genotype is associated with a higher percentage of slow-twitch type I muscle fibres 
(Zhang et al., 2003) and a higher mitochondrial density (Vaughan et al., 2013) in the m. 
vastus lateralis. Therefore, the present study was, to some extent, able to support these cellu-
lar and molecular components of the skeletal muscle by showing that only within the the I/I 
genotype endurance trained subjects had a steeper slopedeoxygenation than untrained subjects. 
This was not the first study showing an interaction effect between the ACE I/D genotype and 
endurance training status on skeletal muscle components. Valdivieso et al. (2017) also found 
interaction effects between the ACE I/D genotype and endurance training status on the CSA 
and MCSA of slow-twitch type I fibres of m. vastus lateralis and therefore on components 
which were related to the skeletal muscle O2 extraction. They could show that untrained carri-
ers of the I allele had a larger CSA than untrained carriers of the D/D genotype. Furthermore, 
trained carriers of the I allele had a larger MCSA than trained carriers of the D/D genotype. In 
the present study, it was also possible to show a genotype-specific difference within the en-
durance untrained subjects. Untrained carriers of the I/D genotype showed a significantly 
steeper slopedeoxygenation (p = 0.017) than untrained carriers of the I/I genotype (-0.065 ± 0.014 
vs. -0.035 ± 0.012 ∆deoxygenation∙s
-1
, respectively). This result is slightly in contrast to the study 
by Valdivieso et al. (2017). Due to the fact that carriers of the D/D genotype were associated 
with a smaller CSA of slow-twitch type I muscle fibres, it could have been assumed that the 
slopedeoxygenation during ramp test is less steep in untrained carriers of the I/D genotype than in 
untrained carriers of the I/I genotype.  
 
4.4 Limitations 
One of the potential limitations of the present study was the small sample size (N = 21). Since 
a codominant model (I/I vs. I/D vs. D/D) was selected for the statistical analysis, the conse-
quence was that the group of the D/D genotype counted only three subjects. In order to im-
prove this limitation, further subjects would have to be included in the study until the desired 
number of subjects, based on a power analysis, is reached for the D/D genotype. Another pos-
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sibility would be to choose another genetic model. In the present study, a recessive model (I/I 
vs. I/D + D/D) could have been chosen instead of a codominant model (I/I vs. I/D vs. D/D). 
A further limitation was that the adipose tissue thickness was not measured above the sensor 
placement for the NIRS measurement. Several studies have shown that adipose tissue can 
influence the NIRS signal (Homma, Fukunaga, & Kagaya, 1996; Niemeijer et al., 2017; Van 
Beekvelt, Borghuis, Van Engelen, Wevers, & Colier, 2001). Since the group studied was a 
heterogeneous group in terms of gender and endurance training status, it can be assumed that 
adipose tissue thickness varied between subjects in the area of NIRS sensor placement. A 
simple way to measure adipose tissue thickness would have been to use a skinfold caliper. A 
far more precise but also more cost intensive method would have been to measure the adipose 
tissue thickness with an ultrasound device. 
Furthermore, the model of NIRS data processing could be refined. As described in the meth-
ods, a linear slope was calculated for the slopedeoxygenation. However, studies have shown that 
the deoxygenation of the muscle during a ramp test is not linear. Belardinelli et al. (1995), for 
example, showed that muscle deoxygenation first reaches a plateau before reaching VO2peak. 
Further authors described a sigmoid curve of muscle deoxygenation during ramp test (Boone 
et al., 2009). By refining the model of NIRS data processing, differences in muscle deoxygen-
ation could be found more sensitively. 
 
4.5 Outlook 
In order to increase the possibility of identifying further effects and to increase the power of 
the study, further subjects should be included in the study. In a further step, the established 
scientific research questions could be answered by means of a longitudinal training interven-
tion study. It would be interesting to investigate whether exercise-induced changes of SmO2 
markers during ramp test are ACE I/D genotype dependent. In a final step, muscle biopsies 
could be collected to investigate the associations between the non-invasive measured SmO2 
markers and cellular and molecular components of the skeletal muscle.  
31 
5 Conclusion 
The present study has shown that in a heterogeneous sample the ACE I/D genotype did not 
have a significant effect on any of the SmO2 markers during ramp test. The endurance training 
status, on contrary, had a significant effect on SmO2 min and ∆deoxygenation as well as a highly 
significant effect on ∆1/2 reoxygenation. Endurance trained subjects showed a greater ∆deoxygenation 
as well as a greater ∆1/2 reoxygenation within the reoxygenation kinetics, indicating an increased 
oxidative capacity of the m. vastus lateralis. Interestingly, a significant interaction effect be-
tween the ACE I/D genotype and endurance training status on the slopedeoxygenation was ob-
served. Trained carriers of the I/I genotype had a highly significant steeper slopedeoxygenation 
than untrained carriers of the I/I genotype. Within carriers of the I/D and the D/D genotype 
there was no significant difference. The highly significant steeper slopedeoxygenation for trained 
subjects only found within the I/I genotype could indicate a higher percentage of slow-twitch 
type I muscle fibres and thus a higher mitochondrial density. Based on these results it could 
be speculated that carriers of the I/I genotype could result in greater adaptability in a longitu-
dinal training study. However, this was not the aim of the present master thesis as it was a 
cross-sectional observation. This pilot study may serve to obtain insightful data into the pos-
sibility of developing specific training programs ad hoc for different patient characteristics. 
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Table 3 
Significance map of the two factor analysis of variance (ANOVA) results 
 ACE I/D Training Status 
 ACE I/D * Training 
Status 
 F value p value F value p value p value p value 
SmO2 baseline 0.284 0.757 0.133 0.721 0.739 0.494 
SmO2 min 0.951 0.408 7.262 0.017* 1.365 0.285 
∆deoxygenation 0.085 0.919 5.499 0.033* 1.883 0.186 
tdeoxygenation 0.647 0.537 0.631 0.439 0.872 0.438 
slopedeoxygenation 0.194 0.826 4.132 0.060 4.585 0.028* 
SmO2 max 0.396 0.680 3.272 0.091 0.112 0.894 
∆1/2 reoxygenation 0.289 0.753 9.611 0.007** 0.359 0.704 
t1/2 reoxygenation 0.047 0.954 0.104 0.752 1.163 0.339 
slope1/2 reoxygenation 0.091 0.913 4.285 0.056 2.572 0.110 
SmO2 overshoot 0.105 0.901 1.251 0.281 1.504 0.254 
Note. Significance map of the two factor analysis of variance (ANOVA) results. Details of SmO2 marker extrac-
tion are presented in section 2.6 Data processing. ACE = angiotensin-converting enzyme, I/D = inser-
tion/deletion. * indicates p < 0.05, ** indicates p < 0.01.  
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